NEW startups: ceramo-metallic, no-UV no-HEPA air purifiers, quick diagnostic devices for malaria, HIV and tuberculosis

The device has been created and tested. The device is designed to purify the air supplied by the ship's ventilation and air conditioning system at a speed of not more than 2 m/s to cabins and other living and service spaces and provides a high level of air purification from smoke, petroleum, formaldehyde, dust, odours, and high neutralisation of viruses (coronaviruses), bacteria and fungi (moulds). Removes up to 99.98% of air pollutants with particle sizes from 0,3 micron. It has a very low ozone release rate of 0.03 ppm. The device does not require replaceable HEPA filters and UV lamps. The device has a low power consumption (60W).
Summary of our air purifier market: the main consumers are the merchant fleet, passenger liners and luxury yachts. According to the IACS, more than 40,000 vessels of various classes have been registered.
At present, the inventors of the air purifier for the residential premises of ships, boats and yachts are assembling a new purifier for HOME (OFFICE) USE.
The startup for both marine and home use devices is up for sale.

Investor wanted.
• Based on preliminary analysis, the global market capacity of the device is estimated to be more than 4.3 billion euros.
• Project implementation period: 12 months from the start of funding.
• We already have: the conceptual approach in implementation, preliminary arrangements, the device development team, directions of project expenses, an approximate amount of payment under contracts to the project participants, a preliminary calculation of profit.
• To complete the development, programming, organisation and conduct of pre- and clinical trials, the team of authors invites a potential investor to become a co-author of a new device and to buy a 40% share in the startup for 2.0 million euros.

Investor wanted.
• Based on preliminary analysis, the global market capacity of the device is estimated to be more than 4.8 billion euros.
• Project implementation period: 12 months from the start of funding.
• We already have: the conceptual approach in implementation, preliminary arrangements, the device development team, directions of project expenses, an approximate amount of payment under contracts to the project participants, a preliminary calculation of profit.
• To complete the development, programming, organisation and conduct of pre- and clinical trials, the team of authors invites a potential investor to become a co-author of a new device and to buy a 40% share in the startup for 2.33 million euros.